A carregar...
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products
OBJECTIVE: We sought to establish the performance of cell-bound complement activation products (CB-CAPs) as a diagnostic tool to distinguish primary fibromyalgia (FM) from systemic lupus erythematosus (SLE). METHODS: A total of 75 SLE and 75 primary FM adult subjects who fulfilled appropriate classi...
Na minha lista:
| Publicado no: | Lupus Sci Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4746498/ https://ncbi.nlm.nih.gov/pubmed/26870391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2015-000127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|